Molly Coye

Dr. Molly Joel Coye has been Executive-in-Residence at AVIA since 2015. From 2010-2015, Dr. Coye served as Chief Innovation Officer for UCLA Health and head of the Institute for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Dr. Coye also advises technology developers, investors, national health systems, and policy makers about disruptive technologies and business models that accelerate transformation.

In 2000, Dr. Coye founded and led HealthTech, which became the premier forecasting organization for emerging technologies in healthcare over the following decade. Prior to that she served as Commissioner of Health for the State of New Jersey, Director of the California Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene.

Dr. Coye is an elected member of the National Academy of Medicine and a member of the board of directors of Amedisys, Ginger, and ConsejoSano, and serves as an advisor to young companies and nonprofit organizations in digital health. From 2005-2018 she was a member of the Board of Directors at Aetna, Inc., and has also been a board member of the American Hospital Association and the American Telemedicine Association, and chaired the board of the American Public Health Association and of PATH, one of the largest nonprofit organizations in global health.